10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001104659-21-100745`
Period End Date	20210630
Filing Date	20210805
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	cldx-20210630x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 67 Cash Flow Statement 61

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$43.45M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$68.03M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$43.84M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$150.59M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$120.59M	USD	Point-in-time
Accounts and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$496.00K	USD	Point-in-time
Accounts and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$1.80M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.62M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Prepaid and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.07M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$167.61M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	39.60M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$197.84M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	39.62M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	39.62M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.81M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.50M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	39.60M	shares	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$2.72M	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$3.45M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$30.69M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$30.69M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$41.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$41.00K	USD	Point-in-time
Total assets	`Assets`	$204.55M	USD	Point-in-time
Total assets	`Assets`	$235.84M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$685.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.05M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$8.46M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$7.85M	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.33M	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.33M	USD	Point-in-time
Current portion of other long-term liabilities	`OtherLiabilitiesCurrent`	$3.37M	USD	Point-in-time
Current portion of other long-term liabilities	`OtherLiabilitiesCurrent`	$4.62M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$14.49M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$14.21M	USD	Point-in-time
Long-term portion of operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$1.45M	USD	Point-in-time
Long-term portion of operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.15M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$6.33M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$10.12M	USD	Point-in-time
Total liabilities	`Liabilities`	$22.27M	USD	Point-in-time
Total liabilities	`Liabilities`	$26.48M	USD	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible preferred stock, $.01 par value; 3,000,000 shares authorized; no shares issued and outstanding at June 30, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Convertible preferred stock, $.01 par value; 3,000,000 shares authorized; no shares issued and outstanding at June 30, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 297,000,000 shares authorized; 39,616,696 and 39,603,771 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$40.00K	USD	Point-in-time
Common stock, $.001 par value; 297,000,000 shares authorized; 39,616,696 and 39,603,771 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$40.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.28B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.28B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.59M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.59M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.07B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.10B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$94.03M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$83.70M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$194.17M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$182.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$238.44M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$209.36M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$204.55M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$235.84M	USD	Point-in-time

Income Statement 67 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.48M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$236.00K	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$4.17M	USD	2 Qtrs
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.96M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$21.40M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$12.36M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$9.71M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$25.08M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$7.19M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$4.31M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$8.43M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.53M	USD	1 Quarter
Intangible asset impairment	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	$3.50M	USD	1 Quarter
Intangible asset impairment	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	$3.50M	USD	2 Qtrs
Loss (gain) on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-741.00K	USD	2 Qtrs
Loss (gain) on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$5.13M	USD	1 Quarter
Loss (gain) on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$4.90M	USD	2 Qtrs
Loss (gain) on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-258.00K	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$11.60M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$27.20M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$34.24M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$16.92M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-30.08M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-11.37M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-13.44M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-24.23M	USD	2 Qtrs
Investment and other income, net	`InterestAndOtherIncome`	$347.00K	USD	2 Qtrs
Investment and other income, net	`InterestAndOtherIncome`	$106.00K	USD	1 Quarter
Investment and other income, net	`InterestAndOtherIncome`	$67.00K	USD	1 Quarter
Investment and other income, net	`InterestAndOtherIncome`	$167.00K	USD	2 Qtrs
Net loss before income tax benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-13.37M	USD	1 Quarter
Net loss before income tax benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-23.88M	USD	2 Qtrs
Net loss before income tax benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-11.26M	USD	1 Quarter
Net loss before income tax benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-29.91M	USD	2 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$900.00K	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-228.00K	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-228.00K	USD	2 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.66M	USD	2 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-13.37M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-16.54M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-12.62M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.91M	USD	2 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.03M	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.76	USD	2 Qtrs
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.34	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-1.20	USD	2 Qtrs
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.50	USD	1 Quarter
Shares used in calculating basic and diluted net loss per share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	39.62M	shares	2 Qtrs
Shares used in calculating basic and diluted net loss per share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	19.74M	shares	2 Qtrs
Shares used in calculating basic and diluted net loss per share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	39.62M	shares	1 Quarter
Shares used in calculating basic and diluted net loss per share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	22.08M	shares	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.66M	USD	2 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-13.37M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-16.54M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-12.62M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.91M	USD	2 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.03M	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-2.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$3.00K	USD	2 Qtrs
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$5.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-22.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-25.00K	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-11.03M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-13.37M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-23.68M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-29.91M	USD	2 Qtrs

Cash Flow Statement 61 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.66M	USD	2 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-13.37M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-16.54M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-12.62M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.91M	USD	2 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.03M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.31M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.54M	USD	2 Qtrs
Amortization and premium of marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$173.00K	USD	2 Qtrs
Amortization and premium of marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$335.00K	USD	2 Qtrs
Gain on sale or disposal of assets	`GainLossOnSaleOfPropertyPlantEquipment`	$24.00K	USD	2 Qtrs
Gain on sale or disposal of assets	`GainLossOnSaleOfPropertyPlantEquipment`	$20.00K	USD	2 Qtrs
Intangible Asset Impairment	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	$3.50M	USD	1 Quarter
Intangible Asset Impairment	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	$3.50M	USD	2 Qtrs
Loss (gain) on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-741.00K	USD	2 Qtrs
Loss (gain) on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$5.13M	USD	1 Quarter
Loss (gain) on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$4.90M	USD	2 Qtrs
Loss (gain) on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-258.00K	USD	1 Quarter
Non-Cash Income Tax Benefit	`IncomeTaxExpenseBenefit`	$900.00K	USD	1 Quarter
Non-Cash Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-228.00K	USD	1 Quarter
Non-Cash Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-228.00K	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$2.78M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$1.41M	USD	2 Qtrs
Accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-686.00K	USD	2 Qtrs
Accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-1.31M	USD	2 Qtrs
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.54M	USD	2 Qtrs
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$436.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-750.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-254.00K	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-3.98M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.41M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-30.01M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-23.33M	USD	2 Qtrs
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$47.00M	USD	2 Qtrs
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$116.00M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$132.44M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$85.74M	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$710.00K	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.15M	USD	2 Qtrs
Proceeds from sale or disposal of assets	`ProceedsFromSaleOfProductiveAssets`	$20.00K	USD	2 Qtrs
Proceeds from sale or disposal of assets	`ProceedsFromSaleOfProductiveAssets`	$24.00K	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-86.56M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$29.57M	USD	2 Qtrs
Net proceeds from stock issuances	`ProceedsFromIssuanceOfCommonStock`	$166.67M	USD	2 Qtrs
Proceeds from issuance of stock from employee benefit plans	`ProceedsFromStockPlans`	$49.00K	USD	2 Qtrs
Proceeds from issuance of stock from employee benefit plans	`ProceedsFromStockPlans`	$24.00K	USD	2 Qtrs
Issuance of Term Loan	`ProceedsFromIssuanceOfDebt`	$2.96M	USD	2 Qtrs
Payment of Term Loan	`RepaymentsOfDebt`	$2.96M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$49.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$166.69M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-390.00K	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$56.80M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$43.45M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$68.03M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$43.84M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$43.45M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$68.03M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$43.84M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Accrued construction in progress	`ConstructionInProgressExpendituresIncurredButNotYetPaid`	$22.00K	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.